market

Innovent Bio, Hutchmed's Tyvyt + Fruquintinib show promising action in colorectal cancer study



Innovent Bio, Hutchmed's Tyvyt + Fruquintinib show promising action in colorectal cancer study



READ SOURCE

Read More   Govt bonds slip, call rates turn lower

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.